Hydrogen Inhalation Alleviates Nonalcoholic Fatty Liver Disease in Metabolic Syndrome Rats

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2020 Sep 18

PMID 32945408

Citations 13

Authors

Boyan Liu

Junli Xue

Mengyu Zhang

Mingyue Wang

Tingting Ma

Min Zhao

Qianqian Gu

Shucun Qin

Affiliations

Soon will be listed here.

Abstract

Hydrogen exhibits therapeutic and preventive effects against various diseases. The present study investigated the potential protective effect and dose‑dependent manner of hydrogen inhalation on high fat and fructose diet (HFFD)‑induced nonalcoholic fatty liver disease (NAFLD) in Sprague‑Dawley rats. Rats were randomly divided into four groups: i) Control group, regular diet/air inhalation; ii) model group, HFFD/air inhalation; iii) low hydrogen group, HFFD/4% hydrogen inhalation; and iv) high hydrogen group, HFFD/67% hydrogen inhalation. After a 10‑week experiment, hydrogen inhalation ameliorated weight gain, abdominal fat index, liver index and body mass index of rats fed with HFFD and lowered the total area under the curve in an oral glucose tolerance test. Hydrogen inhalation also ameliorated the increase in liver lipid content and alanine transaminase and aspartate transaminase activities. Liver histopathologic changes evaluated with hematoxylin and eosin as well as Oil Red O staining revealed lower lipid deposition in hydrogen inhalation groups, consistent with the decrease in the expression of the lipid synthesis gene SREBP‑1c. The majority of the indicators were affected following treatment with hydrogen in a dose‑dependent manner. In conclusion, hydrogen inhalation may play a protective role by influencing the general state, lipid metabolism parameters, liver histology and liver function indicators in the rat model of metabolic syndrome with NAFLD.

Citing Articles

The Protective Role of Molecular Hydrogen in Ischemia/Reperfusion Injury.

Kura B, Slezak J Int J Mol Sci. 2024; 25(14).

PMID: 39063126 PMC: 11276695. DOI: 10.3390/ijms25147884.

Hydrogen therapy promotes macrophage polarization to the M2 subtype in radiation lung injury by inhibiting the NF-κB signalling pathway.

Gao X, Niu S, Li L, Zhang X, Cao X, Zhang X Heliyon. 2024; 10(10):e30902.

PMID: 38826750 PMC: 11141264. DOI: 10.1016/j.heliyon.2024.e30902.

The Molecular Biological Mechanism of Hydrogen Therapy and Its Application in Spinal Cord Injury.

Hu Q, Li Y, Lin Z, Zhang H, Chen H, Chao C Drug Des Devel Ther. 2024; 18:1399-1414.

PMID: 38707612 PMC: 11068043. DOI: 10.2147/DDDT.S463177.

Hydrogen: A Rising Star in Gas Medicine as a Mitochondria-Targeting Nutrient via Activating Keap1-Nrf2 Antioxidant System.

Cheng D, Long J, Zhao L, Liu J Antioxidants (Basel). 2023; 12(12).

PMID: 38136182 PMC: 10740752. DOI: 10.3390/antiox12122062.

Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside.

Xie F, Song Y, Yi Y, Jiang X, Ma S, Ma C Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111299 PMC: 10141176. DOI: 10.3390/ph16040541.

References

Eckel R, Alberti K, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2010; 375(9710):181-3. DOI: 10.1016/S0140-6736(09)61794-3. View

Tu L, Showalter M, cajka T, Fan S, Pillai V, Fiehn O . Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Sci Rep. 2017; 7(1):6120. PMC: 5522413. DOI: 10.1038/s41598-017-05040-6. View

Li H, Chen O, Ye Z, Zhang R, Hu H, Zhang N . Inhalation of high concentrations of hydrogen ameliorates liver ischemia/reperfusion injury through A receptor mediated PI3K-Akt pathway. Biochem Pharmacol. 2017; 130:83-92. DOI: 10.1016/j.bcp.2017.02.003. View

Tsatsoulis A, Mantzaris M, Bellou S, Andrikoula M . Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective. Metabolism. 2012; 62(5):622-33. DOI: 10.1016/j.metabol.2012.11.004. View

Browning J, Horton J . Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004; 114(2):147-52. PMC: 449757. DOI: 10.1172/JCI22422. View

Panchal S, Brown L . Rodent models for metabolic syndrome research. J Biomed Biotechnol. 2011; 2011:351982. PMC: 3018657. DOI: 10.1155/2011/351982. View

Kim D, Touros A, Kim W . Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Clin Liver Dis. 2017; 22(1):133-140. DOI: 10.1016/j.cld.2017.08.010. View

Hashimoto M, Katakura M, Nabika T, Tanabe Y, Hossain S, Tsuchikura S . Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model. Med Gas Res. 2011; 1(1):26. PMC: 3231949. DOI: 10.1186/2045-9912-1-26. View

Song G, Tian H, Qin S, Sun X, Yao S, Zong C . Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Atherosclerosis. 2012; 221(1):55-65. DOI: 10.1016/j.atherosclerosis.2011.11.043. View

10.

Sanyal A, Pacana T . A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease. Trans Am Clin Climatol Assoc. 2015; 126:271-88. PMC: 4530706. View

11.

Valenzuela R, Videla L . The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct. 2011; 2(11):644-8. DOI: 10.1039/c1fo10133a. View

12.

Dole M, Wilson F, FIFE W . Hyperbaric hydrogen therapy: a possible treatment for cancer. Science. 1975; 190(4210):152-4. DOI: 10.1126/science.1166304. View

13.

Aragno M, Tomasinelli C, Vercellinatto I, Catalano M, Collino M, Fantozzi R . SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med. 2009; 47(7):1067-74. DOI: 10.1016/j.freeradbiomed.2009.07.016. View

14.

Sanders F, McNally B, Griffin J . Blood triacylglycerols: a lipidomic window on diet and disease. Biochem Soc Trans. 2016; 44(2):638-44. DOI: 10.1042/BST20150235. View

15.

Younossi Z, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H . Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011; 9(6):524-530.e1. DOI: 10.1016/j.cgh.2011.03.020. View

16.

Paquette A, Wang D, Jankowski M, Gutkowska J, Lavoie J . Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver. Menopause. 2008; 15(6):1169-75. DOI: 10.1097/gme.0b013e31817b8159. View

17.

Choi K, Kim H, Do S, Hwang S, Yi H . Neuroprotective effects of hydrogen inhalation in an experimental rat intracerebral hemorrhage model. Brain Res Bull. 2018; 142:122-128. DOI: 10.1016/j.brainresbull.2018.07.006. View

18.

Song G, Zong C, Zhang Z, Yu Y, Yao S, Jiao P . Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice. Free Radic Biol Med. 2015; 87:58-68. DOI: 10.1016/j.freeradbiomed.2015.06.018. View

19.

Chen O, Cao Z, Li H, Ye Z, Zhang R, Zhang N . High-concentration hydrogen protects mouse heart against ischemia/reperfusion injury through activation of thePI3K/Akt1 pathway. Sci Rep. 2017; 7(1):14871. PMC: 5665927. DOI: 10.1038/s41598-017-14072-x. View

20.

Juurlink D, Gomes T, Lipscombe L, Austin P, Hux J, Mamdani M . Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ. 2009; 339:b2942. PMC: 2728804. DOI: 10.1136/bmj.b2942. View